Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neurol Sci ; 35(5): 683-5, 2014 May.
Article in English | MEDLINE | ID: mdl-24277200

ABSTRACT

The rural district of the Meuse (East France) has a high number of elderly patients for whom prognosis of ischaemic strokes is poor with high-haemorrhagic transformation risk of intravenous tissue plasminogen activator (rt-PA). This disadvantage is made worse by the distances a patient has to travel to the nearest stroke unit. We set out to assess the effectiveness of a telestroke system implemented in this area. Between October 2010 and February 2012, data from each "tele-expertised" patient were collected. 53 patients were examined. Diagnosis of ischaemic stroke was confirmed in 43 cases (81 %), and intravenous rt-PA treatment performed in 21 cases (40 %). In the treated patient group, median age was 73 years, with 29 % of octogenarians. Baseline National Institutes of Health Stroke Scale (NIHSS) was 16, with 29 % ≥ 20. The median onset to needle time was 169 min, and the median door to needle time was 69 min. Intracranial haemorrhage occurred in 3 cases (14 %), and was symptomatic in two (10 %). At 3 months, median NIHSS was 6, 6 patients (29 %) presented a favourable outcome (modified Rankin scale ≤ 1) and 3 (14 %) had died. In rural areas, for elderly patients with severe ischaemic strokes, telemedicine appears to be a way of improving accessibility and benefits of rt-PA treatment.


Subject(s)
Brain Ischemia/therapy , Rural Health Services , Stroke/therapy , Telemedicine/methods , Administration, Intravenous , Adult , Aged , Aged, 80 and over , Brain Ischemia/complications , Female , Fibrinolytic Agents/administration & dosage , France , Humans , Intracranial Hemorrhages/etiology , Male , Middle Aged , Rural Health Services/statistics & numerical data , Severity of Illness Index , Stroke/complications , Telemedicine/statistics & numerical data , Thrombolytic Therapy/methods , Thrombolytic Therapy/statistics & numerical data , Time Factors , Tissue Plasminogen Activator/administration & dosage , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...